Keith Norris to Antihypertensive Agents
This is a "connection" page, showing publications Keith Norris has written about Antihypertensive Agents.
Connection Strength
2.665
-
Shen JI, Nicholas SB, Williams S, Norris KC. Evidence for and Against ACC/AHA 2017 Guideline for Target Systolic Blood Pressure of
View in: PubMed
Score: 0.572
Norris KC, Brown AF. The Highs and Lows of Blood Pressure Targets in Elderly Adults and Other High-Risk Populations. J Am Geriatr Soc. 2015 Oct; 63(10):2139-41.
Score: 0.429
Norris K, Neutel JM. Emerging insights in the first-step use of antihypertensive combination therapy. J Clin Hypertens (Greenwich). 2007 Dec; 9(12 Suppl 5):5-14.
Score: 0.249
Duru OK, Vargas RB, Kermah D, Pan D, Norris KC. Health insurance status and hypertension monitoring and control in the United States. Am J Hypertens. 2007 Apr; 20(4):348-53.
Score: 0.238
Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD, Wright JT, Wang X, Greene T, Appel LJ, Lewis J. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis. 2006 Nov; 48(5):739-51.
Score: 0.231
Martins D, Norris K. Combating diabetic nephropathy with drug therapy. Curr Diab Rep. 2001 Oct; 1(2):148-56.
Score: 0.163
Weinberg JM, Appel LJ, Bakris G, Gassman JJ, Greene T, Kendrick CA, Wang X, Lash J, Lewis JA, Pogue V, Thornley-Brown D, Phillips RA. Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy. Arch Intern Med. 2009 Sep 28; 169(17):1587-94.
Score: 0.142
Kusek JW, Lee JY, Charleston J, Faulkner M, Levell B, Milligan S, Norris K. Participant satisfaction in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996 Aug; 17(4 Suppl):47S-54S.
Score: 0.114
Norris KC, Nicholas SB. Strategies for Controlling Blood Pressure and Reducing Cardiovascular Disease Risk in Patients with Chronic Kidney Disease. Ethn Dis. 2015 Nov 05; 25(4):515-20.
Score: 0.108
Martins D, Agodoa L, Norris KC. Hypertensive chronic kidney disease in African Americans: strategies for improving care. Cleve Clin J Med. 2012 Oct; 79(10):726-34.
Score: 0.087
Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010 Sep 02; 363(10):918-29.
Score: 0.075
Bhatnagar V, O'Connor DT, Brophy VH, Schork NJ, Richard E, Salem RM, Nievergelt CM, Bakris GL, Middleton JP, Norris KC, Wright J, Hiremath L, Contreras G, Appel LJ, Lipkowitz MS. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions. Am J Hypertens. 2009 Mar; 22(3):332-8.
Score: 0.067
Martins D, Tareen N, Nicholas SB, Jones L, Norris KC. Education, motivation and medication for African Americans: bringing hypertension guidelines to practice. Ethn Dis. 2004; 14(4):S2-38-41.
Score: 0.048
Norris K, Vaughn C. The role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease. Expert Rev Cardiovasc Ther. 2003 May; 1(1):51-63.
Score: 0.045
Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT, Xu S. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001 Jun 06; 285(21):2719-28.
Score: 0.040
Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wright JT. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens. 1996 Aug; 9(8):719-25.
Score: 0.028
Bhatnagar V, O'Connor DT, Schork NJ, Salem RM, Nievergelt CM, Rana BK, Smith DW, Bakris GL, Middleton JP, Norris KC, Wright JT, Cheek D, Hiremath L, Contreras G, Appel LJ, Lipkowitz MS. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial. J Hypertens. 2007 Oct; 25(10):2082-92.
Score: 0.015
Appel LJ, Middleton J, Miller ER, Lipkowitz M, Norris K, Agodoa LY, Bakris G, Douglas JG, Charleston J, Gassman J, Greene T, Jamerson K, Kusek JW, Lewis JA, Phillips RA, Rostand SG, Wright JT. The rationale and design of the AASK cohort study. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S166-72.
Score: 0.011